Brand semaglutide retails for roughly $1,349\/month for Wegovy\u00ae and $968\/month for Ozempic\u00ae without insurance, per Novo Nordisk list prices as of 2025. Compounded semaglutide through telehealth platforms typically runs $199-$399\/month depending on dose and provider. The price gap is substantial, but the comparison isn’t apples-to-apples.<\/p>\n
Insurance coverage for brand semaglutide is inconsistent. Most commercial plans cover Ozempic for type 2 diabetes but exclude Wegovy for weight loss. Medicare Part D excludes anti-obesity medications by statute. Medicaid coverage varies by state. The result: most people paying out of pocket pay full retail unless they qualify for the Novo Nordisk savings card.<\/p>\n
This breakdown covers brand pricing, compounded pricing, insurance landscape, savings programs, and how to think about long-term total cost.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
Wegovy list price is $1,349.02 per 28-day pen package, regardless of dose strength.<\/strong> Ozempic list price is $968.52 per 28-day supply. Both are set by Novo Nordisk and apply across all doses, since the 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg pens cost the same per box.<\/p>\n Quick Answer: Wegovy list price: $1,349\/month (28-day supply); Ozempic: $968\/month<\/p>\n Walgreens, CVS, and Rite Aid carry both. Cash pay prices may vary by 5-15% from list. Costco often runs slightly below list. GoodRx coupons offer minimal discount on brand GLP-1s, typically under 5%, because Novo Nordisk doesn’t participate in the discount card networks at meaningful levels.<\/p>\n Over a full year at full retail, Wegovy runs about $16,188 and Ozempic about $11,622. For 18 months (typical to reach full response), that’s $24,000-$29,000 out of pocket without insurance.<\/p>\n Compounded semaglutide bypasses the brand markup.<\/strong> The active ingredient costs the compounding pharmacy a small fraction of the retail price. Without R&D recovery, marketing, and brand profit margins, the same molecule can be prepared and shipped for $200-$400\/month.<\/p>\n Compounding became legal at scale because of the FDA shortage list. When the FDA declared semaglutide in shortage in 2022, 503A and 503B pharmacies were permitted to prepare bulk compounded versions for individual prescriptions. In October 2024 the FDA removed semaglutide from the shortage list, which initially threatened the compounded supply, but state pharmacy boards and federal court rulings have continued to permit personalized compounded preparations under section 503A of the Federal Food, Drug, and Cosmetic Act when clinically justified.<\/p>\n Typical telehealth pricing as of 2025: $199-$249\/month for 0.25-0.5 mg doses, $249-$349 for 1.0-1.7 mg, and $299-$399 for 2.4 mg maintenance doses. TrimRx offers transparent pricing as part of the personalized treatment plan, with a free assessment quiz to determine eligibility.<\/p>\n Ozempic coverage for type 2 diabetes is broad.<\/strong> Most commercial plans, Medicare Part D, and Medicaid programs cover Ozempic when prescribed for diabetes management with an A1c on record above 6.5%.<\/p>\n Wegovy coverage for weight loss is patchy. Roughly 30-40% of commercial plans cover Wegovy with prior authorization, requiring documented BMI \u226530 (or \u226527 with comorbidities), failed lifestyle attempts, and ongoing diet and exercise programs. Self-funded employer plans often exclude anti-obesity medications entirely. State Medicaid programs cover Wegovy in about 20 states, including California, Pennsylvania, and Michigan as of 2025.<\/p>\n Medicare Part D cannot cover Wegovy under current statute except when prescribed for cardiovascular risk reduction in patients with established cardiovascular disease, an indication added by FDA in March 2024 based on the SELECT trial. This narrow indication has expanded Medicare coverage modestly but most weight-only prescriptions remain uncovered.<\/p>\n The Wegovy savings card brings out-of-pocket cost to $0\/month for commercially insured patients whose plans cover Wegovy, up to $225 off per fill, capped at $1,800 per year.<\/strong> For patients whose commercial plans don’t cover Wegovy, the card offers up to $500 off per fill, bringing cost to roughly $849\/month.<\/p>\n The Ozempic savings card offers similar tiered savings: $25\/month for covered patients (12 fills) and up to $150 off per fill for uncovered commercial patients.<\/p>\n Government insurance patients (Medicare, Medicaid, VA, Tricare) cannot use the manufacturer savings card. Cash-pay patients without any insurance also don’t qualify for the highest tier of savings. The card requires commercial insurance even if the plan doesn’t cover the drug.<\/p>\n Eli Lilly’s tirzepatide brands (Mounjaro for diabetes, Zepbound for weight loss) carry list prices of about $1,069\/month for Mounjaro and $1,059\/month for Zepbound at the smaller 5 mg and 10 mg doses.<\/strong> The new Lilly Direct cash pay option launched in 2024 offers Zepbound vials at $349-$499\/month for 2.5 mg and 5 mg, the first major price break for a brand GLP-1.<\/p>\n Compounded tirzepatide tracks compounded semaglutide pricing, typically $279-$499\/month. The clinical efficacy edge favors tirzepatide (20.9% weight loss vs 14.9% in head-to-head population studies), but cost considerations vary by individual.<\/p>\n For a typical 18-month course to reach and maintain full response, here are the cash-pay totals:<\/p>\n Compounded semaglutide: $200-$400\/month \u00d7 18 = $3,600-$7,200 total<\/p>\n Wegovy with savings card and uncovered commercial insurance: $849\/month \u00d7 18 = $15,282<\/p>\n Wegovy at full retail: $1,349\/month \u00d7 18 = $24,282<\/p>\n Wegovy with savings card and covered commercial insurance: $0-$225\/month \u00d7 18 = $0-$4,050<\/p>\n For long-term maintenance past the initial titration year, the same per-month cost continues. Many patients budget $2,400-$5,000 annually for compounded semaglutide maintenance or $0-$3,000 for covered Wegovy.<\/p>\n A 2024 cost-effectiveness analysis in JAMA Network Open estimated that semaglutide 2.4 mg at retail price is not cost-effective at standard willingness-to-pay thresholds when limited to weight loss alone.<\/strong> When cardiovascular benefits from the SELECT trial are included, cost-effectiveness improves but still exceeds typical thresholds.<\/p>\n At compounded pricing, the math changes. Compounded semaglutide produces the same drug exposure at 15-25% of the retail price, putting it well within cost-effective range for weight loss and metabolic benefits.<\/p>\n That said, brand and compounded are not regulatory equivalents. Brand drugs have FDA approval for specific indications with manufacturer-controlled quality. Compounded drugs are state-pharmacy regulated, lot-by-lot. The cost gap reflects regulatory pathway, not chemistry.<\/p>\n Key Takeaway: Medicare Part D cannot cover anti-obesity drugs by federal law; bipartisan legislation has been proposed but not passed<\/p>\n Patient assistance programs through Novo Nordisk Patient Assistance Program cover uninsured patients earning under approximately 400% of federal poverty level (about $60,240 for a single person in 2025).<\/strong> The program provides Wegovy at no cost for qualifying patients but requires income documentation and physician application.<\/p>\n HSA and FSA accounts cover prescription GLP-1 medications including compounded versions when prescribed for a qualifying medical condition. Pre-tax savings effectively reduce cost by 20-37% depending on tax bracket.<\/p>\n Some employers offer obesity care benefits through specialized programs. Check with HR for weight management benefits, which sometimes cover Wegovy or telehealth programs even when general medical insurance excludes anti-obesity drugs.<\/p>\n Verify the pharmacy is properly licensed.<\/strong> For compounded semaglutide, ask whether the pharmacy is 503A (traditional compounding) or 503B (FDA-registered outsourcing facility), the state where it operates, and whether they perform third-party potency and sterility testing.<\/p>\n Ask about all-in pricing. The advertised monthly price should include the medication, provider visits, syringes, and shipping. Hidden fees for re-evaluation, refills, or shipping add 10-30% to the headline price at some platforms.<\/p>\n Confirm refill flexibility and cancellation policy. Some platforms require 3-6 month commitments. Others bill monthly with month-to-month cancellation. Lock-ins are not standard and shouldn’t be necessary for a chronic medication.<\/p>\n Most telehealth platforms charge an all-in monthly fee that bundles medication, provider visits, syringes, and shipping.<\/strong> A few break these out separately. The all-in approach makes comparison easier; the unbundled approach can hide fees.<\/p>\n Typical fee structures:<\/p>\n Some platforms require a 3-6 month commitment with a single payment; others offer monthly billing. Monthly billing with the option to cancel anytime is generally more patient-friendly.<\/p>\n Eligibility labs are usually not included in the headline monthly price.<\/strong> Most platforms accept labs from your primary care provider or partner with direct-to-consumer labs (Quest, LabCorp) for affordable testing.<\/p>\n Typical eligibility labs include A1c, complete metabolic panel, and lipid panel. Cash price at DTC labs runs $50-$150 for the full set. Insurance often covers these labs when ordered through primary care.<\/p>\n Follow-up labs at 3-6 months are typical for ongoing monitoring. Same cost structure applies.<\/p>\n Treat semaglutide like a long-term medication, similar to a statin or blood pressure drug.<\/strong> The total cost matters but so does sustainability. Switching pharmacies mid-treatment is fine, but disruptions to dosing can set back progress.<\/p>\n Many patients budget around $250-$400\/month for compounded semaglutide as a fixed monthly expense, similar to a gym membership or streaming bundle. Insurance-covered brand can be cheaper but is also subject to formulary changes year over year.<\/p>\n The cardiovascular and metabolic benefits beyond weight loss strengthen the value case for long-term maintenance.<\/p>\n Bottom line: GoodRx and discount cards rarely apply meaningful savings to Wegovy or Ozempic<\/p>\n Brand price reflects R&D, FDA approval, marketing, manufacturer profit, and US healthcare market pricing. Compounded versions skip those layers by preparing the active ingredient under state pharmacy regulation rather than New Drug Application pathway.<\/p>\n Rarely. Compounded medications aren’t on standard insurance formularies because they’re individualized prescriptions, not FDA-approved drugs with NDC codes. Some HSA\/FSA accounts reimburse them, but standard commercial insurance does not.<\/p>\n Yes. The active ingredient is the same. Your prescriber can write for brand semaglutide once insurance approves it. Continue at the same dose level; no re-titration needed.<\/p>\n Not much. GoodRx coupons on Wegovy are typically under 5% off list. The Novo Nordisk savings card offers far better savings for eligible commercial insurance patients.<\/p>\n Some prices have risen in 2024-2025 as compounding pharmacies face stricter FDA enforcement and supply chain costs. The range has shifted upward from $199-$299 to $249-$399 at many platforms. Brand prices have held relatively flat.<\/p>\n For commercially insured patients with Wegovy coverage and the savings card, $0\/month is possible. For uninsured or government-insured patients, compounded semaglutide at $200-$400\/month is the lowest-cost legitimate route. Avoid online pharmacies that don’t require a prescription or operate from non-licensed jurisdictions.<\/p>\n Bipartisan legislation has been introduced repeatedly to allow Medicare Part D to cover anti-obesity medications, but none has passed as of 2025. The 2024 cardiovascular indication opened limited Medicare access but the broader weight-loss indication remains excluded.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n <\/p>\n Brand semaglutide retails for roughly $1,349\/month for Wegovy and $968\/month for Ozempic without insurance, per Novo Nordisk list prices as of 2025.<\/p>\n","protected":false},"author":11,"featured_media":92673,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Compounded Semaglutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options","_yoast_wpseo_metadesc":"Brand semaglutide retails for roughly $1,349\/month for Wegovy and $968\/month for Ozempic without insurance, per Novo Nordisk list prices as of 2025.","_yoast_wpseo_focuskw":"compounded semaglutide cost","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[7],"tags":[22,23,30,46],"class_list":["post-89289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-semaglutide","tag-compounded","tag-cost-coverage","tag-insurance","tag-semaglutide"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=89289"}],"version-history":[{"count":4,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89289\/revisions"}],"predecessor-version":[{"id":93674,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89289\/revisions\/93674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/92673"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=89289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=89289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=89289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Why Is Compounded Semaglutide So Much Cheaper?<\/h2>\n
What Insurance Plans Cover Wegovy or Ozempic?<\/h2>\n
How Does the Novo Nordisk Savings Card Work?<\/h2>\n
What About Mounjaro\u00ae and Zepbound\u00ae for Comparison?<\/h2>\n
What Are Realistic Monthly Budgets?<\/h2>\n
What About the Long-term Value Question?<\/h2>\n
Are There Other Ways to Save?<\/h2>\n
What Questions Should I Ask Before Starting?<\/h2>\n
How Do Telehealth Platform Fees Compare?<\/h2>\n
\n
What About Lab Costs?<\/h2>\n
How Should I Think About Year-over-year Costs?<\/h2>\n
FAQ<\/h2>\n
Why Is Brand Wegovy So Much More Expensive Than Compounded?<\/h3>\n
Will Insurance Ever Cover Compounded Semaglutide?<\/h3>\n
Can I Switch From Compounded to Brand If I Get Coverage Later?<\/h3>\n
Is GoodRx Useful for Wegovy?<\/h3>\n
Are Compounded Prices Going Up?<\/h3>\n
What’s the Cheapest Legitimate Option for Semaglutide?<\/h3>\n
Will Medicare Cover Wegovy in the Future?<\/h3>\n
Related Articles<\/h2>\n
\n